Company intelligence / Profile preview

Merit Medicine

Ownership: Private
Development stage: Commercial

Overview

Merit Medicine provides an AI-driven platform that leverages billions of data points to deliver highly accurate predictive insights into healthcare risk and spend. Their technology enables early identification of high-risk members, forecasts claims costs up to 18 months in advance, optimizes underwriting precision for stop-loss carriers and plan sponsors, and supports proactive interventions to improve financial outcomes

Therapeutic areas: Other
Industry: Biomedical IT and Biomedical Data Platforms

Beyond the preview

Go deeper on Merit Medicine.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Merit Medicine.

Explore the full profile